120 related articles for article (PubMed ID: 28074480)
21. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
22. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
23. Trisomy 8 in myeloid leukemia cutis confirmed by fluorescence in situ hybridization analysis.
Shvartsbeyn M; Meehan SM; Gu P; Nierodzik ML; Perle MA
J Cutan Pathol; 2012 Nov; 39(11):1026-9. PubMed ID: 22882450
[TBL] [Abstract][Full Text] [Related]
24. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
McClintock-Treep SA; Horny HP; Sotlar K; Foucar MK; Reichard KK
J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
[TBL] [Abstract][Full Text] [Related]
25. Systemic mastocytosis (SM) and associated malignant bone marrow histiocytosis - a hitherto undescribed form of SM-AHNMD.
Rudzki Z; Sotlar K; Kudela A; Starzak-Gwóźdź J; Horny HP
Pol J Pathol; 2011; 62(2):101-4. PubMed ID: 21866466
[TBL] [Abstract][Full Text] [Related]
26. Involvement of eosinophils in acute myeloid leukaemia with monosomy 7 demonstrated by fluorescence in situ hybridization.
Kwong YL; Chan LC
Br J Haematol; 1994 Oct; 88(2):389-91. PubMed ID: 7803286
[TBL] [Abstract][Full Text] [Related]
27. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
[TBL] [Abstract][Full Text] [Related]
28. Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
Marbello L; Anghilieri M; Nosari A; Minola E; Cairoli R; Ricci F; Morra E
Haematologica; 2004 Sep; 89(9):ECR35. PubMed ID: 15377487
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia (AML-M2) with mast cell hyperplasia of bone marrow: a report of three cases.
Adhya AK; Varma N; Varma S
Indian J Pathol Microbiol; 2007 Jul; 50(3):655-8. PubMed ID: 17883174
[TBL] [Abstract][Full Text] [Related]
30. Diffuse cutaneous reticulohistiocytosis.
Goette DK; Odom RB; Fitzwater JE
Arch Dermatol; 1982 Mar; 118(3):173-6. PubMed ID: 6950687
[TBL] [Abstract][Full Text] [Related]
31. Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.
Escribano L; Garca-Montero A; Núñez-López R; López-Jiménez J; Almeida J; Prados A; Orfao A
J Allergy Clin Immunol; 2004 Jul; 114(1):28-33. PubMed ID: 15241340
[TBL] [Abstract][Full Text] [Related]
32. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
Wiednig M; Beham-Schmid C; Kranzelbinder B; Aberer E
Dermatology; 2013; 227(1):67-71. PubMed ID: 24008407
[TBL] [Abstract][Full Text] [Related]
33. Concurrent acute myeloid leukemia and systemic mastocytosis.
Wong KF; Chan JK; Chan JC; Kwong YL; Ma SK; Chow TC
Am J Hematol; 1991 Nov; 38(3):243-4. PubMed ID: 1951328
[TBL] [Abstract][Full Text] [Related]
34. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
35. Aggressive systemic mastocytosis.
Inaoui R; Petit B; Jaccard A; Bertin P; Trèves R
Joint Bone Spine; 2003 Feb; 70(1):64-6. PubMed ID: 12639621
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology.
Brockow K; Akin C; Huber M; Metcalfe DD
J Am Acad Dermatol; 2003 Apr; 48(4):508-16. PubMed ID: 12664011
[TBL] [Abstract][Full Text] [Related]
37. Systemic mastocytosis associated with acute myeloid leukemia.
Nogueira FL; Martins NNN; Cardoso PSR; Murao M; de Melo FHC; Glória ABF; Fagundes EM
Ann Hematol; 2020 Jan; 99(1):195-196. PubMed ID: 31768674
[No Abstract] [Full Text] [Related]
38. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
39. Papular exanthem discloses acute myeloid leukaemia: interphase fluorescence in situ hybridization revealed deletion of p53 and gain at 8q22/8q24/Tel8q without trisomy 8.
Kaune KM; Baumgart M; Schmitke E; Haase D; Middel P; Ghadimi BM; Bertsch HP; Neumann C; Emmert S
Clin Exp Dermatol; 2010 Mar; 35(2):160-4. PubMed ID: 19438543
[TBL] [Abstract][Full Text] [Related]
40. Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone.
Hussein K; Horny HP; Büsche G; Görner M; Göhring G; Kreipe H; Bock O
Leukemia; 2011 Jun; 25(6):1050-3. PubMed ID: 21445078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
